Concepedia

Publication | Open Access

Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis

1.1K

Citations

23

References

2014

Year

Abstract

More patients with ANCA-associated vasculitides had sustained remission at month 28 with rituximab than with azathioprine. (Funded by the French Ministry of Health; MAINRITSAN ClinicalTrials.gov number, NCT00748644; EudraCT number, 2008-002846-51.).

References

YearCitations

Page 1